John J. Brennan,Franz Schaefer,Melissa E. Wigderson
申请号：
US15211781
公开号：
US20170014386A1
申请日:
2016.07.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure provides compositions and methods for treating multidrug-resistant nephrotic syndrome (MDR-NS) in pediatric subjects comprising atrasentan. Methods of reducing protenuria in a pediatric patient having MDR-NS are also provided.
